Skip to content

Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia (AML)

  • Authors

    • Prof. Simone Thomas

    • Prof. Simone Thomas

  • Date Published

    August 31, 2021

Jetani H, Navarro-Bailón A, Maucher M, Frenz S, Verbruggen C, Yeguas A, Vidriales MB, González M, Saborido JR, Kraus S, Mestermann K, Thomas S, Bonig H, Luu M, Monjezi R, Mougiakakos D, Sauer M, Einsele H, Hudecek M. Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia (AML). Blood 2021; 138(19):1830. doi: 10.1182/blood.2020009192. PMID: 34289026